NorthStar Asset Management (Pennsylvania)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,294
Closed -$742K 115
2018
Q3
$742K Sell
8,294
-276
-3% -$24.4K 0.29% 71
2018
Q2
$681K Sell
8,570
-3,765
-31% -$313K 0.28% 71
2018
Q1
$1.1M Buy
12,335
+410
+3% +$39.4K 0.46% 58
2017
Q4
$1.25M Sell
11,925
-9,295
-44% -$1.05M 0.51% 55
2017
Q3
$3.09M Buy
21,220
+11,830
+126% +$1.61M 1.36% 20
2017
Q2
$1.22M Buy
9,390
+40
+0.4% +$4.9K 0.55% 51
2017
Q1
$1.16M Sell
9,350
-200
-2% -$23.9K 0.52% 50
2016
Q4
$1.1M Sell
9,550
-50
-0.5% -$5.57K 0.5% 50
2016
Q3
$1M Sell
9,600
-200
-2% -$21.6K 0.42% 57
2016
Q2
$967K Hold
9,800
0.4% 57
2016
Q1
$981K Hold
9,800
0.42% 53
2015
Q4
$1.17M Sell
9,800
-20
-0.2% -$2.31K 0.5% 49
2015
Q3
$1.06M Hold
9,820
0.48% 50
2015
Q2
$1.14M Buy
9,820
+700
+8% +$80K 0.48% 51
2015
Q1
$1.05M Sell
9,120
-400
-4% -$47.8K 0.45% 51
2014
Q4
$1.06M Sell
9,520
-1,500
-14% -$158K 0.46% 52
2014
Q3
$1.04M Buy
11,020
+150
+1% +$13.5K 0.45% 53
2014
Q2
$933K Buy
+10,870
New +$827K 0.4% 54

Other funds holding CELG

NorthStar Asset Management (Pennsylvania)'s CELG Position: Q4 2018 in Review

NorthStar Asset Management (Pennsylvania) sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 8,294 shares — an estimated $742K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in CELG in Q2 2014 and held it in 18 quarters. The position peaked at $3.09M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • NorthStar Asset Management (Pennsylvania) reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • NorthStar Asset Management (Pennsylvania) sold 8,294 Celgene Corp shares in Q4 2018, an estimated $742K.
  • NorthStar Asset Management (Pennsylvania) first reported a position in Celgene Corp in Q2 2014 and held it in 18 quarters.
  • NorthStar Asset Management (Pennsylvania)'s Celgene Corp position peaked at $3.09M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q4 2018, filed 4 Feb 2019.